Increased Incidence of Herpes Zoster and @entity14000 in Adult XXXX following @entity131 : A Nationwide Population-Based Study in Taiwan.

@entity1 @entity14000 @entity131 @entity4091
The aims of this study were to estimate the incidences of @entity4091 ( @entity4091 ) and @entity14000 ( @entity14000 ) in @entity1 after @entity131 ( @entity131 ). Furthermore, we aimed to explore the risk factors of the development of @entity4091 and @entity14000 in @entity1 after @entity131 . This population-based, longitudinal analysis was conducted using the Taiwan National Health Insurance Research Database (consisting of 1,000,000 beneficiaries) from 1996 to 2010. Using the longitudinal National Health Insurance Research Database, we conducted a retrospective population-based cohort study to evaluate the incidence of @entity4091 and @entity14000 in adult @entity131 @entity1 and controls. Kaplan-Meier analysis and Cox regression were used to compare differences in the development of @entity4091 and @entity14000 . The effects of gender, comorbidity and surgery on the risk of @entity4091 and @entity14000 development were assessed by subgroup analyses. Over a 15-year follow-up, the cumulative incidence of @entity4091 in 28,234 @entity131 @entity1 (604.00/100,000 @entity1 -years) was significantly higher than 34,085 controls (322.21/100,000 @entity1 -years) (P<0.0001, by log-rank test). Females showed a significantly higher incidence of @entity4091 than males (p for interaction = 0.0010). The time to @entity4091 development in the follow-up period was 5.9 years in @entity131 @entity1 compared to 9.9 years in the control set (p <0.0001). @entity131 @entity1 were 2.93 and 2.11 times likely to develop @entity4091 and @entity14000 , respectively, than the general population. The incidences of @entity4091 and @entity14000 in @entity131 @entity1 were also significantly greater than for controls in the CCI = 0 subgroup. To our knowledge, this is the first population-based cohort study to reveal that @entity131 is an independent risk factor for @entity4091 and @entity14000 in @entity131 @entity1 , especially in females. Physician should pay attention to the possibility of @entity4091 and @entity14000 in @entity131 @entity1 and be aware that @entity4091 vaccination early after @entity131 may lower the incidence of @entity4091 and @entity14000 .
